TrialCancer research communications2025

Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer.

Robert W Lentz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.